RecruitingNCT03378856

Evaluation of Technological Innovation in Radiotherapy

Partnership Initiative for the Evaluation of Technological Innovation in Radiotherapy


Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Enrollment

1,500 participants

Start Date

Nov 1, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

Prospective cohort study of patients receiving standard-care radiotherapy is paramount to a better understanding of radiation effects and longterm outcomes. The primary objective is to determine the feasibility of establishing infrastructure to systematically collect clinical data, patient-reported outcomes, and imaging data from daily radiotherapy practice. Secondary objectives are to provide a control cohort for comparative effectiveness research of investigational interventions through a cmRCT design; compare imaging features with clinical outcomes; understand dose-effect relationships; quantify imaging quality metrics.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Ability to provide informed consent
  • Receiving radiotherapy or brachytherapy

Exclusion Criteria1

  • \-

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(5)

London Health Regional Cancer Centre

London, Ontario, Canada

Princess Margaret Cancer Centre

Toronto, Ontario, Canada

Centre de santé et de services sociaux de Laval

Laval, Quebec, Canada

Centre Hospitalier de l'Université de Montréal

Montreal, Quebec, Canada

CHUQ

Québec, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03378856


Related Trials